otsa101-dtpa-90y
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2011 (NCT01469975)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Frizzled-10Immunity, passive
FZD10 immunity, passive
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- otsa101-dtpa-90y
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04176016 | Phase 1 | Jan 31, 2020 | OncoTherapy Science, Inc. |
| NCT01469975 | Phase 1 | Dec 1, 2011 | Centre Leon Berard, OncoTherapy Science, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| OncoTherapy Science, Inc. | For profit | 2 | 1 | 1 | 2011 |
| Centre Leon Berard | Academic/Hospital | 1 | 1 | 1 | 2011 |
2 organizations
Page 1 / 1